CClinicalTrials.gg
CompletedNCT00816751Updated Aug 13, 2019Results posted

Paracervical Versus Intracervical Lidocaine

An interventional study of Paracervical block and Intracervical in Abortion, Induced and Pain, sponsored by University of California, San Diego. Completed at 1 site in United States. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-13.

Sponsored by University of California, San Diego · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
89
Allocation
Randomized
Ages
18 Years and older
Sex
Female
01

Study summary

The aim of this study is to estimate the efficacy of intracervical versus paracervical block on pain experienced during first trimester suction curettage without the use of preoperative cervical ripening. Because of the theoretical improved reliability of stromal block, the investigators hypothesize that intracervical block would produce lower pain scores than paracervical block at the time of cervical dilation.

02

Conditions studied

  • Abortion, Induced
  • Pain

Keywords

  • Local anesthesia
  • Paracervical
  • Intracervical
  • Abortion
  • Pain
  • Local anesthesia for elective first trimester abortion
03

In context

Lead sponsor

University of California, San Diego is the lead sponsor of 958 studies on the registry; 191 are open to participants now.

Of its 110 completed or terminated interventional studies of FDA-regulated products, 70 (64%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Women presenting for elective first trimester abortion

Exclusion criteria

Exclusion Criteria:

  • Gestation over 12 weeks by ultrasound
  • Weight less than 98 pounds
  • Known allergy to lidocaine
  • Known nonviable pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
89 participants (actual)

Study arms

  • Active comparator
    1

    Procedure: Paracervical block · Drug: Buffered Lidocaine, vasopressin, sodium bicarbonate

  • Experimental
    2

    Procedure: Intracervical · Drug: Buffered Lidocaine, vasopressin, sodium bicarbonate

Interventions

  • ProcedureParacervical block

    The paracervical block was administered using 20 ml of buffered lidocaine and a 5/8 inch, 25-gauge needle. A small amount was injected at the tenaculum site, and the remainder equally distributed around the cervicovaginal junction at 3, 5, 7, and 9 o'clock. The depth was standardized at 5/8 inch by inserting the needle to the hub.

  • ProcedureIntracervical

    The intracervical block was administered using 20 ml of buffered lidocaine and a 1-1/2 inch, 20 gauge needle in order to overcome the increased resistance to injection caused by the cervical stroma. A small amount was injected at the tenaculum site, and the remainder into the cervical stroma at 12, 3, 6, and 9 o'clock, at a depth of 1-1/2 inch by inserting the needle to the hub.

  • DrugBuffered Lidocaine, vasopressin, sodium bicarbonate

    The buffered lidocaine preparation for both block techniques consisted of 50 mL of 1% lidocaine, 5 units of vasopressin, and 5 mL 8% sodium bicarbonate.

06

What researchers measure

Primary outcomes

  1. Pain Score, as Assessed Using a 10 cm Linear Visual Analog Scale (VAS)

    VAS on a scale of 1 to 10 with 1 being lowest pain and 10 highest amount of pain

    Time frame: at completion of procedure

Secondary outcomes

  1. Gestational Age at Time of Procedure

    Time frame: At the time of the procedure

07

Results

Posted Aug 13, 2019

Participant flow

Participant flow — Overall Study
MilestoneParacervical BlockIntracervical Block
Started4544
Completed4544
Not completed00

Outcome measures

PrimaryPain Score, as Assessed Using a 10 cm Linear Visual Analog Scale (VAS)

VAS on a scale of 1 to 10 with 1 being lowest pain and 10 highest amount of pain

Time frame:
at completion of procedure
Reported as:
Mean · units on a scale
Pain Score, as Assessed Using a 10 cm Linear Visual Analog Scale (VAS)
units on a scaleParacervical BlockIntracervical Block
Pain Score, as Assessed Using a 10 cm Linear Visual Analog Scale (VAS)4.25 ± 0.63.97 ± 0.5
SecondaryGestational Age at Time of Procedure
Time frame:
At the time of the procedure
Reported as:
Mean · Days
Gestational Age at Time of Procedure
DaysParacervical BlockIntracervical Block
Gestational Age at Time of Procedure51 ± 1154 ± 9

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Paracervical Block0/45 (0%)0/45 (0%)0/45 (0%)
Intracervical Block0/44 (0%)0/44 (0%)0/44 (0%)

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Paracervical BlockIntracervical BlockTotal
<=18 years000
Between 18 and 65 years454489
>=65 years000
Sex: Female, Male
Sex: Female, Male(Participants)Paracervical BlockIntracervical BlockTotal
Female454489
Male000
08

Study locations

1 site
  • Planned Parenthood
    San Diego, California 92101, United States
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 13, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00816751
Lead sponsor
University of California, San Diego
Responsible party
Jessica Kingston (Clinical Professor, University of California, San Diego) — Principal investigator
First posted
Jan 5, 2009
Start date
Dec 2007
Primary completion
Feb 2008
Completion
Feb 2008
Results posted
Aug 13, 2019
Last update
Aug 13, 2019

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion